Mitochondrial SIRT3: A new potential therapeutic target for metabolic syndrome

Molecular Cell

Volumn 44, Issue 2, 2011, Pages 170-171

  Yoshino, Jun ^a   Imai, Shin ichiro ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; MITOCHONDRIAL PROTEIN; SIRTUIN 3;

ACETYLATION; DEACETYLATION; DRUG TARGETING; ENZYME ACTIVITY; FATTY ACID OXIDATION; HUMAN; HYPERACETYLATION; INSULIN RESISTANCE; LIPID DIET; METABOLIC SYNDROME X; NONHUMAN; PATHOGENESIS; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 82455175476     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2011.10.005     Document Type: Short Survey

References (10)

1. Guan K.L., Xiong Y. Trends Biochem. Sci. 2011, 36:108-116.
2. Hirschey M.D., Shimazu T., Goetzman E., Jing E., Schwer B., Lombard D.B., Grueter C.A., Harris C., Biddinger S., Ilkayeva O.R., et al. Nature 2010, 464:121-125.
3. Hirschey M.D., Shimazu T., Jing E., Grueter C.A., Collins A.M., Aouizerat B., Stančáková A., Goetzman E., Lam M.M., Schwer B., et al. Mol. Cell 2011, 44:177-190. this issue.
4. Imai S., Guarente L. Trends Pharmacol. Sci. 2010, 31:212-220.
5. Jing E., Emanuelli B., Hirschey M.D., Boucher J., Lee K.Y., Lombard D., Verdin E.M., Kahn C.R. Proc. Natl. Acad. Sci. USA 2011, 108:14608-14613.
6. Jitrapakdee S., Wutthisathapornchai A., Wallace J.C., MacDonald M.J. Diabetologia 2010, 53:1019-1032.
7. Lanza I.R., Short D.K., Short K.R., Raghavakaimal S., Basu R., Joyner M.J., McConnell J.P., Nair K.S. Diabetes 2008, 57:2933-2942.
8. Nakagawa T., Lomb D.J., Haigis M.C., Guarente L. Cell 2009, 137:560-570.
9. Someya S., Yu W., Hallows W.C., Xu J., Vann J.M., Leeuwenburgh C., Tanokura M., Denu J.M., Prolla T.A. Cell 2010, 143:802-812.
10. Yoshino J., Mills K.F., Yoon M.J., Imai S. Cell Metab. 2011, 14:528-536.